BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15994854)

  • 1. Increase in tension-dependent ATP consumption induced by cardiac troponin T mutation.
    Chandra M; Tschirgi ML; Tardiff JC
    Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H2112-9. PubMed ID: 15994854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac troponin T mutations: correlation between the type of mutation and the nature of myofilament dysfunction in transgenic mice.
    Montgomery DE; Tardiff JC; Chandra M
    J Physiol; 2001 Oct; 536(Pt 2):583-92. PubMed ID: 11600691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent FHC-related cardiac troponin T mutations exhibit specific alterations in myocellular contractility and calcium kinetics.
    Haim TE; Dowell C; Diamanti T; Scheuer J; Tardiff JC
    J Mol Cell Cardiol; 2007 Jun; 42(6):1098-110. PubMed ID: 17490679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca(2+) activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T.
    Chandra M; Rundell VL; Tardiff JC; Leinwand LA; De Tombe PP; Solaro RJ
    Am J Physiol Heart Circ Physiol; 2001 Feb; 280(2):H705-13. PubMed ID: 11158969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal and mutation-specific alterations in Ca2+ homeostasis differentially determine the progression of cTnT-related cardiomyopathies in murine models.
    Guinto PJ; Haim TE; Dowell-Martino CC; Sibinga N; Tardiff JC
    Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H614-26. PubMed ID: 19502551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic cardiomyopathy mutation in cardiac troponin T (R95H) attenuates length-dependent activation in guinea pig cardiac muscle fibers.
    Mickelson AV; Chandra M
    Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1180-H1189. PubMed ID: 28842439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis associated with a restrictive cardiomyopathy mutant in cardiac troponin T is due to reduced protein stability and greatly increased myofilament Ca2+ sensitivity.
    Parvatiyar MS; Pinto JR
    Biochim Biophys Acta; 2015 Feb; 1850(2):365-72. PubMed ID: 25450489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The N-terminal extension of cardiac troponin T stabilizes the blocked state of cardiac thin filament.
    Gollapudi SK; Mamidi R; Mallampalli SL; Chandra M
    Biophys J; 2012 Sep; 103(5):940-8. PubMed ID: 23009843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of R92 mutations in mouse cardiac troponin T are influenced by changes in myosin heavy chain isoform.
    Ford SJ; Mamidi R; Jimenez J; Tardiff JC; Chandra M
    J Mol Cell Cardiol; 2012 Oct; 53(4):542-51. PubMed ID: 22884844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca(2+)-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy.
    Morimoto S; Lu QW; Harada K; Takahashi-Yanaga F; Minakami R; Ohta M; Sasaguri T; Ohtsuki I
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):913-8. PubMed ID: 11773635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilated cardiomyopathy mutation (R174W) in troponin T attenuates the length-mediated increase in cross-bridge recruitment and myofilament Ca
    Reda SM; Chandra M
    Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H648-H657. PubMed ID: 31373515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac myosin heavy chain isoform exchange alters the phenotype of cTnT-related cardiomyopathies in mouse hearts.
    Rice R; Guinto P; Dowell-Martino C; He H; Hoyer K; Krenz M; Robbins J; Ingwall JS; Tardiff JC
    J Mol Cell Cardiol; 2010 May; 48(5):979-88. PubMed ID: 20004663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F110I and R278C troponin T mutations that cause familial hypertrophic cardiomyopathy affect muscle contraction in transgenic mice and reconstituted human cardiac fibers.
    Hernandez OM; Szczesna-Cordary D; Knollmann BC; Miller T; Bell M; Zhao J; Sirenko SG; Diaz Z; Guzman G; Xu Y; Wang Y; Kerrick WG; Potter JD
    J Biol Chem; 2005 Nov; 280(44):37183-94. PubMed ID: 16115869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hypertrophic cardiomyopathy mutations from different functional regions of troponin T result in different effects on the pH and Ca2+ sensitivity of cardiac muscle contraction.
    Harada K; Potter JD
    J Biol Chem; 2004 Apr; 279(15):14488-95. PubMed ID: 14722098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T.
    Sumandea MP; Pyle WG; Kobayashi T; de Tombe PP; Solaro RJ
    J Biol Chem; 2003 Sep; 278(37):35135-44. PubMed ID: 12832403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional consequence of mutation in rat cardiac troponin T is affected differently by myosin heavy chain isoforms.
    Tschirgi ML; Rajapakse I; Chandra M
    J Physiol; 2006 Jul; 574(Pt 1):263-73. PubMed ID: 16644804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T-tropomyosin interaction and causes a Ca2+ desensitization.
    Lu QW; Morimoto S; Harada K; Du CK; Takahashi-Yanaga F; Miwa Y; Sasaguri T; Ohtsuki I
    J Mol Cell Cardiol; 2003 Dec; 35(12):1421-7. PubMed ID: 14654368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cardiac troponin T N-terminal deletion and phosphorylation on myofilament function.
    Sumandea MP; Vahebi S; Sumandea CA; Garcia-Cazarin ML; Staidle J; Homsher E
    Biochemistry; 2009 Aug; 48(32):7722-31. PubMed ID: 19586048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myosin regulatory light chain E22K mutation results in decreased cardiac intracellular calcium and force transients.
    Szczesna-Cordary D; Jones M; Moore JR; Watt J; Kerrick WG; Xu Y; Wang Y; Wagg C; Lopaschuk GD
    FASEB J; 2007 Dec; 21(14):3974-85. PubMed ID: 17606808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Calmodulin-Kinase II Activation Drives Disease Progression in Mutation-Specific Hypertrophic Cardiomyopathy.
    Lehman SJ; Tal-Grinspan L; Lynn ML; Strom J; Benitez GE; Anderson ME; Tardiff JC
    Circulation; 2019 Mar; 139(12):1517-1529. PubMed ID: 30586744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.